Similar to the current study, the DELIVER 2 and DELIVER 3 studies25,26 reported that in people with type 2 diabetes who switched basal insulin, rates of both hypoglycemia and hypoglycemia associated with inpatient/ED visits were significantly lower in people who switched to Gla-300 vs Gla-100 or IDet 100 U/mL. The gene discussed is INS; the disease is Hypoglycemia.